In addition, in a double transgenic mouse model of AD (APP/PS1), a review of the neuroprotective potential of AP suggested that apigenin could enhance AD-associated memory impairment, decrease the load of Aβ plaque, and inhibit oxidative stress [92]. Here, APP is linked to Alzheimer disease.